Lountzis Asset Management LLC Sells 55 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Lountzis Asset Management LLC lowered its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 0.5% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 11,440 shares of the healthcare conglomerate’s stock after selling 55 shares during the period. UnitedHealth Group accounts for 2.7% of Lountzis Asset Management LLC’s holdings, making the stock its 12th biggest position. Lountzis Asset Management LLC’s holdings in UnitedHealth Group were worth $5,826,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also modified their holdings of UNH. Signature Resources Capital Management LLC grew its holdings in UnitedHealth Group by 40.0% in the 2nd quarter. Signature Resources Capital Management LLC now owns 63 shares of the healthcare conglomerate’s stock valued at $32,000 after buying an additional 18 shares in the last quarter. Saxony Capital Management LLC boosted its stake in UnitedHealth Group by 3.5% in the second quarter. Saxony Capital Management LLC now owns 530 shares of the healthcare conglomerate’s stock valued at $270,000 after acquiring an additional 18 shares in the last quarter. GoalVest Advisory LLC increased its holdings in shares of UnitedHealth Group by 0.6% in the 2nd quarter. GoalVest Advisory LLC now owns 3,124 shares of the healthcare conglomerate’s stock valued at $1,591,000 after acquiring an additional 18 shares during the period. Continuum Advisory LLC grew its stake in shares of UnitedHealth Group by 0.6% in the 2nd quarter. Continuum Advisory LLC now owns 3,410 shares of the healthcare conglomerate’s stock valued at $1,737,000 after purchasing an additional 19 shares during the last quarter. Finally, Veracity Capital LLC increased its stake in shares of UnitedHealth Group by 1.5% during the first quarter. Veracity Capital LLC now owns 1,335 shares of the healthcare conglomerate’s stock worth $660,000 after acquiring an additional 20 shares during the period. Institutional investors and hedge funds own 87.86% of the company’s stock.

Insider Activity at UnitedHealth Group

In other UnitedHealth Group news, CAO Thomas E. Roos sold 2,851 shares of the firm’s stock in a transaction dated Wednesday, July 17th. The shares were sold at an average price of $569.88, for a total value of $1,624,727.88. Following the completion of the sale, the chief accounting officer now owns 29,501 shares of the company’s stock, valued at $16,812,029.88. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. In other news, CAO Thomas E. Roos sold 2,851 shares of UnitedHealth Group stock in a transaction on Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total value of $1,624,727.88. Following the transaction, the chief accounting officer now directly owns 29,501 shares in the company, valued at approximately $16,812,029.88. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, EVP Erin Mcsweeney sold 1,500 shares of the business’s stock in a transaction on Thursday, July 18th. The shares were sold at an average price of $579.03, for a total transaction of $868,545.00. Following the sale, the executive vice president now directly owns 7,785 shares in the company, valued at $4,507,748.55. The disclosure for this sale can be found here. 0.33% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

A number of brokerages have recently weighed in on UNH. Barclays raised their price target on UnitedHealth Group from $560.00 to $604.00 and gave the company an “overweight” rating in a research report on Wednesday, July 17th. Jefferies Financial Group raised UnitedHealth Group from a “hold” rating to a “buy” rating and boosted their price target for the company from $481.00 to $647.00 in a research report on Wednesday, July 17th. UBS Group upped their price target on shares of UnitedHealth Group from $640.00 to $680.00 and gave the stock a “buy” rating in a research report on Thursday, July 18th. Royal Bank of Canada lifted their price target on shares of UnitedHealth Group from $555.00 to $615.00 and gave the stock an “outperform” rating in a research note on Wednesday, July 17th. Finally, StockNews.com upgraded UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Friday. One analyst has rated the stock with a hold rating, nineteen have issued a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, the company has a consensus rating of “Buy” and a consensus target price of $614.17.

UnitedHealth Group Trading Up 1.0 %

UNH stock traded up $5.90 during trading on Tuesday, hitting $596.10. 341,077 shares of the company traded hands, compared to its average volume of 4,079,066. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.88 and a current ratio of 0.88. The company has a 50-day moving average of $550.35 and a 200-day moving average of $512.88. The firm has a market capitalization of $550.45 billion, a PE ratio of 36.08, a P/E/G ratio of 1.64 and a beta of 0.58. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $598.17.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, July 16th. The healthcare conglomerate reported $6.80 EPS for the quarter, topping the consensus estimate of $6.66 by $0.14. The business had revenue of $98.86 billion for the quarter, compared to the consensus estimate of $98.73 billion. UnitedHealth Group had a return on equity of 26.55% and a net margin of 3.66%. During the same period in the previous year, the company posted $6.14 earnings per share. The company’s revenue for the quarter was up 6.4% compared to the same quarter last year. Analysts predict that UnitedHealth Group Incorporated will post 27.67 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, September 24th. Shareholders of record on Monday, September 16th will be issued a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a yield of 1.41%. The ex-dividend date is Monday, September 16th. UnitedHealth Group’s dividend payout ratio is currently 51.34%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.